Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Cash from Operations (2021 - 2025)

Senti Biosciences has reported Cash from Operations over the past 5 years, most recently at 6875000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 49.09% year-over-year to 6875000.0; the TTM value through Dec 2025 reached 43444000.0, down 4.94%, while the annual FY2025 figure was 43444000.0, 4.94% down from the prior year.
  • Cash from Operations for Q4 2025 was 6875000.0 at Senti Biosciences, up from 9446000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 934675.0 in Q2 2021 and troughed at 16304000.0 in Q1 2023.
  • A 5-year average of 9223997.26 and a median of 9446000.0 in 2025 define the central range for Cash from Operations.
  • Biggest five-year swings in Cash from Operations: plummeted 868.08% in 2022 and later soared 49.09% in 2025.
  • Year by year, Cash from Operations stood at 1142247.0 in 2021, then crashed by 688.45% to 9006000.0 in 2022, then increased by 21.86% to 7037000.0 in 2023, then plummeted by 91.9% to 13504000.0 in 2024, then soared by 49.09% to 6875000.0 in 2025.
  • Business Quant data shows Cash from Operations for SNTI at 6875000.0 in Q4 2025, 9446000.0 in Q3 2025, and 13073000.0 in Q2 2025.